As for ACSL3, it has been shown that the antiproliferative effect of Vitamin D in prostate cancer cells is mediated by ACSL3 overexpression, an effect that is blocked by Triacsin C [34]. The gene discussed is ACSL3; the disease is prostate carcinoma.